-+ 0.00%
-+ 0.00%
-+ 0.00%

BD And Ypsomed Strengthen Collaboration With Development Of 5.5 mL Version Of BD Neopak XtraFlow Glass Prefillable Syringe

Benzinga·01/21/2026 11:52:20
Listen to the news

The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systems

LE PONT-DE-CLAIX, France and BURGDORF, Switzerland, Jan. 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.